NeoGenomics Inc logo

NeoGenomics Inc

$ 12.07 +0.49 (+4.23%) 10:09 PM EST
P/E:
At Loss
P/B:
1.51
Market Cap:
$ 1.52B
Enterprise V:
$ 1.63B
Volume:
931.33K
Avg Vol (2M):
1.39M
Also Trade In:
Volume:
931.33K
Market Cap $:
1.52B
PE Ratio:
At Loss
Avg Vol (2-Month):
1.39M
Enterprise Value $:
1.63B
PB Ratio:
1.51

Business Description

Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.
Name Current Vs Industry Vs History
Cash-To-Debt 0.73
Equity-to-Asset 0.58
Debt-to-Equity 0.6
Debt-to-EBITDA -5.8
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.38
Distress
Grey
Safe
Beneish M-Score -2.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 79.41
9-Day RSI 73.32
14-Day RSI 69.11
6-1 Month Momentum % 3.97
12-1 Month Momentum % -73.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.1
Quick Ratio 6.82
Cash Ratio 5.22
Days Inventory 26.14
Days Sales Outstanding 81
Days Payable 22.21

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -9.5